Per Omvik

12.4k citations
131 papers · 10k · 2 hit papers · h-index 28

Impact in

    • Blood Pressure and Hypertension Studies
    • Renin-Angiotensin System Studies
    • Cardiovascular Function and Risk Factors
    • Cardiovascular Health and Disease Prevention
    • Heart Failure Treatment and Management
  • Nephrology top 0.5%
    • Chronic Kidney Disease and Diabetes
    • Gout, Hyperuricemia, Uric Acid

Papers in

Per Omvik

125 papers receiving 8.9k citations

Per Omvik's Hit Papers

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol 2002 · 4.3k citations
4.3k0+8+16Years since publication1k2k3k4k

Peers

Per Omvik
Comparison fields: 5 of 114
  • Cardiology and Cardiovascular Medicine 7.1k
  • Nephrology 1.2k
  • Endocrinology, Diabetes and Metabolism 795
  • Nutrition and Dietetics 182
  • Complementary and alternative medicine 114
Replace Yuhei Kawano with:
Yuhei Kawano Japan
Toshihiko Ishimitsu Japan
Gareth Beevers United Kingdom
A Castaigne France
Shinichiro Ueda Japan
Colin I. Johnston Australia
K. H. Rahn Germany
Marcel Lebel Canada
Roberto Pedrinelli Italy
Ole Lederballe‐Pedersen Sweden
Per Omvik relative to Yuhei Kawano Japan Yuhei Kawano's profile →
Citations per field
00.5×1.5×
Yuhei Kawano · 1×
Citations per year

Countries citing papers authored by Per Omvik

Since Specialization
Citations

This map shows the geographic impact of Per Omvik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per Omvik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per Omvik more than expected).

Fields of papers citing papers by Per Omvik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Per Omvik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per Omvik. The network helps show where Per Omvik may publish in the future.

Co-authors

The 25 scholars most cited alongside Per Omvik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Per Omvik Line = papers co-authored together Per Omvik links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 131 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
Hit paper breakdown →
20024324
2
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
Hit paper breakdown →
20021209
3 2005458
4 2004389
5 2002346
6 2002321
7 1998262
8 2006189
9 1996181
10 1990153
11 1998127
12 2004108
13 199596
14 200788
15 199382
16 200480
17 198079
18 198967
19 198659
20 200053

About Per Omvik

Per Omvik is a scholar working on Cardiology and Cardiovascular Medicine, Nutrition and Dietetics, Nephrology, Complementary and alternative medicine and Hematology, having authored 131 papers that have together received 10k indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (100 papers), Sodium Intake and Health (13 papers), Renin-Angiotensin System Studies (8 papers), Cardiovascular Function and Risk Factors (6 papers), Cardiovascular and exercise physiology (4 papers), Chronic Kidney Disease and Diabetes (4 papers), Iron Metabolism and Disorders (4 papers) and Cardiovascular Health and Disease Prevention (3 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (7.1k citations), Nephrology (1.2k citations), Endocrinology, Diabetes and Metabolism (795 citations), Nutrition and Dietetics (182 citations) and Complementary and alternative medicine (114 citations). Per Omvik has collaborated with scholars based in Norway, United States and Finland. Frequent co-authors include Richard B. Devereux, Sverre Erik Kjeldsen, Stevo Julius, Markku S. Nieminen, Ole Lederballe‐Pedersen, Lars Hjalmar Lindholm, Hans Ibsen, Frej Fyhrquist, Ulf dé Fairé and Hans Wedel. Their work appears in journals such as Journal of Hypertension, Blood Pressure, Hypertension, Journal of Cardiovascular Pharmacology and Cardiovascular Drugs and Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact